Live Well with Michelle

Hosted by Michelle Martin, this episode previews a pivotal week for investors as earnings season kicks off with JPMorgan Chase and Netflix, while fresh inflation data and renewed U.S.-Iran tensions add another layer of uncertainty. We unpack Bank of America's top earnings picks, ask whether AI momentum can continue after standout performances from SK Hynix and Meta.

Michelle speaks with the first Gastroenterologist in Singapore to be recognised as a National Fellow by World Obesity Federation, to find out about advances in weight control. As science transforms our understanding of obesity, experts now recognise it as a chronic disease shaped by biology, hormones and the brain - not just lifestyle choices. Hosted by Michelle Martin in conversation with Dr Ravishankar Asok-kumar, Senior Consultant, Gastroenterologist and Advanced Therapeutic Endoscopist at Singapore General Hospital, this episode explores why weight regain is so common, where GLP-1 medications and new minimally invasive treatments fit, and why personalised obesity care could change not just our weight, but our long-term health, confidence and quality of life. 

Should you buy a REIT before it recovers? How can you tell if a REIT is on the path of recovery? Michelle finds out in this discussion as more investors ask if Singapore's beaten-down property trusts are finally turning the corner, or if the rebound is only temporary. After years of higher interest rates and weaker distributions, investors are looking for signs of a sustained recovery. Hosted by Michelle Martin, this episode examines three REITs to watch: Mapletree Logistics Trust, Mapletree Pan Asia Commercial Trust and Frasers Centrepoint Trust. We explore what their upcoming results could reveal about logistics demand, retail resilience, asset recycling, financing costs and the transformative potential of the Johor Bahru–Singapore RTS Link. If you're hunting for income, this conversation highlights the metrics that matter most before making your next investment decision.

In this episode, hosted by Michelle Martin, we unpack SK Hynix's record-breaking US$26.5 billion U.S. listing and why investors are pouring money into the critical infrastructure powering artificial intelligence. We explore Meta's move into AI coding, OpenAI's launch of its long-awaited AI "super app," and the growing legal battle over whether AI companies should compensate news publishers for the content that trains their models. We also check in on a steadier Wall Street as geopolitical tensions ease and examine what calmer markets mean for investors. Finally, we look at why the next stage of the AI revolution may be won not just by software developers- but by the companies building the chips, memory and infrastructure behind it.

Artificial intelligence has transformed the way we work, but could the next computing revolution come from biology instead? Hosted by Michelle Martin, this episode explores the groundbreaking field of biological computing with Dr Chong Hon Weng, Founder and CEO of Cortical Labs. Discover how lab-grown human neurons are being fused with silicon chips to create computers that learn in fundamentally different ways from today's AI. We explore why Singapore is home to the country's first Biological Data Centre, how this technology could accelerate drug discovery for neurological diseases, dramatically reduce AI's energy consumption, and reshape robotics, cybersecurity and healthcare. Finally, Dr Chong tackles the ethical questions surrounding the use of living human brain cells and shares his vision for the future of intelligence itself.

In this episode, hosted by Michelle Martin, Tim Phillips, founder of TimTalksMoney, explores whether new lower-cost global ETFs genuinely challenge VWRA or whether fund size, liquidity and tracking matter more than headline fees. We examine why institutional investors are pouring back into Singapore equities and whether record-high prices for DBS, OCBC and UOB still leave room for further gains. The conversation also tackles one of the year's biggest investor dilemmas: should you rebalance after a volatile first half of 2026, or stay the course? Beyond Singapore, we assess whether Hong Kong dividend stalwarts like CLP Holdings, BOC Hong Kong and MTR offer attractive diversification alongside local banks and REITs. Finally, we discuss where CapitaLand Integrated Commercial Trust and Frasers Centrepoint Trust fit into an income portfolio and the key market catalysts investors should watch through the rest of 2026.

Temasek's biggest increase in China investments in five years raises a fascinating question: what is long-term capital seeing that others may be missing?  Hosted by Michelle Martin, we unpack the Singapore investment giant's AI-driven strategy as its portfolio surpasses S$400 billion. We also examine how rising oil prices, Fed uncertainty and geopolitical tensions are rattling global markets, while more than two-thirds of technology stocks have slipped into correction territory. Plus, why Levi Strauss is outperforming expectations by reinventing denim for a new generation of consumers. In our Up or Down segment, we look at Broadcom, Apple, SpaceX, Luxshare, and South Korean equities to find out where momentum is building - and where investors are losing confidence.

Michelle Martin's guest started her business after a health challenge when she faced the prospect of having to take medication to manage an autoimmune disease for life. That kicked off the start of her deep dive into one of our most powerful senses that is often overlooked.  Our sense of smell has a direct connection to the brain's emotional and memory centres, making fragrance far more than a pleasant luxury. Hosted by Michelle Martin, this episode explores essential oils, stress, sleep, focus and workplace wellbeing with Michelle Sim, Founder of Sixth Senses Aromatics and a Duke-certified Health & Wellbeing Coach. 

Has the first half of 2026 quietly rewritten the investing playbook? Markets have climbed despite geopolitical tensions, sticky interest rates and lofty valuations - but is the rally becoming broader and more durable?  Hosted by Michelle Martin, this investor debate brings together Arun Pai, Partner of Monk's Hill Ventures and Alvin Chow, Co-founder of Dr Wealth to challenge conventional wisdom on where opportunities - and risks - lie for the rest of the year.  From sectors to avoid to markets worth buying, the duo shares their highest-conviction ideas in a rapid-fire showdown. If you're wondering whether your portfolio is still positioned for what's next, this episode offers fresh perspectives to help shape your second-half strategy.

Hosted by Michelle Martin, we unpack why AI stocks dragged global markets lower despite broader market resilience and what that signals for investors. We explore why the consumer discretionary sector has become Wall Street's biggest laggard - and whether it could be the market's next opportunity. In our UP or DOWN segment, we assess Samsung's bid to stay ahead of Apple in foldable smartphones and the overwhelming demand for SK Hynix's blockbuster US listing. Closer to home, we examine Singapore stocks in focus, including Frasers Property, ESR-REIT and Foundation Healthcare, and what their latest developments could mean for shareholders.